Gene therapy improves immune function in preadolescents with X-linked severe combined immunodeficiency

被引：65
|
作者：
Chinen, Javier
Davis, Joie
De Ravin, Suk See
Hay, Beverly N.
Hsu, Amy P.
Linton, Gilda F.
Naumann, Nora
Nomicos, Effie Y. H.
Silvin, Christopher
Ulrick, Jean
Whiting-Theobald, Narda L.
Malech, Harry L.
Puck, Jennifer M.
机构：
[1] NIAID, Host Def Lab, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA
[2] NHGRI, Genet & Mol Biol Branch, NIAID, NIH,DHHS, Bethesda, MD 20892 USA
来源：
BLOOD | 2007年 / 110卷 / 01期
关键词：
BONE-MARROW-TRANSPLANTATION; CHRONIC GRANULOMATOUS-DISEASE; STEM-CELL TRANSPLANTATION; T-CELL; CD34(+) CELLS; TRANSDUCTION; SCID-X1; SURVIVAL; MODEL; IL2RG;
D O I：
10.1182/blood-2006-11-058933
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Retroviral gene therapy can restore immunity to infants with X-linked severe combined immunodeficiency (XSCID) caused by mutations in the IL2RG gene encoding the common gamma chain (gamma c) of receptors for interleukins 2 (IL-2), -4, -7, -9, -15, and -21. We investigated the safety and efficacy of gene therapy as salvage treatment for older XSCID children with inadequate immune reconstitution despite prior bone marrow transplant from a parent. Subjects received retrovirus-transduced autologous peripherally mobilized CD34(+) hematopoletic cells. T-cell function significantly improved in the youngest subject (age 10 years), and multilineage retroviral marking occurred in all 3 children.
引用
收藏
页码：67 / 73
页数：7
相关论文
共 50 条
  • [21] Multiple Reversions of an IL2RG Mutation Restore T cell Function in an X-linked Severe Combined Immunodeficiency Patient
    Kawai, Tomoki
    Saito, Megumu
    Nishikomori, Ryuta
    Yasumi, Takahiro
    Izawa, Kazushi
    Murakami, Tomohiko
    Okamoto, Shigefumi
    Mori, Yasuko
    Nakagawa, Noriko
    Imai, Kohsuke
    Nonoyama, Shigeaki
    Wada, Taizo
    Yachie, Akihiro
    Ohmori, Katsuyuki
    Nakahata, Tatsutoshi
    Heike, Toshio
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 (04) : 690 - 697
  • [22] Keratinocyte Antiviral Response to Poly(dA:dT) Stimulation and Papillomavirus Infection in a Canine Model of X-Linked Severe Combined Immunodeficiency
    Luff, Jennifer A.
    Yuan, Hang
    Kennedy, Douglas
    Schlegel, Richard
    Felsburg, Peter
    Moore, Peter F.
    PLOS ONE, 2014, 9 (07):
  • [23] Gene/Cell Therapy Approaches for Immune Dysregulation Polyendocrinopathy Enteropathy X-Linked Syndrome
    Passerini, Laura
    de Sio, Francesca R. Santoni
    Porteus, Matthew H.
    Bacchetta, Rosa
    CURRENT GENE THERAPY, 2014, 14 (06) : 422 - 428
  • [24] Limiting Thymic Precursor Supply Increases the Risk of Lymphoid Malignancy in Murine X-Linked Severe Combined Immunodeficiency
    Ginn, Samantha L.
    Hallwirth, Claus V.
    Liao, Sophia H. Y.
    Teber, Erdahl T.
    Arthur, Jonathan W.
    Wu, Jianmin
    Lee, Hong Ching
    Tay, Szun S.
    Hu, Min
    Reddel, Roger R.
    McCormack, Matthew P.
    Thrasher, Adrian J.
    Cavazzana, Marina
    Alexander, Stephen I.
    Alexander, Ian E.
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2017, 6 : 1 - 14
  • [25] Generation of knockout rabbits with X-linked severe combined immunodeficiency (X-SCID) using CRISPR/Cas9
    Hashikawa, Yoshiko
    Hayashi, Ryuhei
    Tajima, Masaru
    Okubo, Toru
    Azuma, Shohei
    Kuwamura, Mitsuru
    Takai, Naofumi
    Osada, Yasuyuki
    Kunihiro, Yayoi
    Mashimo, Tomoji
    Nishida, Kohji
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [26] Gene Therapy for Severe Combined Immunodeficiency due to Adenosine Deaminase Deficiency
    Montiel-Equihua, Claudia A.
    Thrasher, Adrian J.
    Gaspar, H. Bobby
    CURRENT GENE THERAPY, 2012, 12 (01) : 57 - 65
  • [27] The Landscape of Hematopoietic Stem Cell Transplant and Gene Therapy for X-Linked Adrenoleukodystrophy
    Mallack, Eric J.
    Turk, Bela
    Yan, Helena
    Eichler, Florian S.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2019, 21 (12)
  • [28] Update on gene therapy for adenosine deaminase-deficient severe combined immunodeficiency
    Ferrua, Francesca
    Brigida, Immacolata
    Aiuti, Alessandro
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 10 (06) : 551 - 556
  • [29] Lentiviral gene therapy for X-linked chronic granulomatous disease
    Kohn, Donald B.
    Booth, Claire
    Kang, Elizabeth M.
    Pai, Sung-Yun
    Shaw, Kit L.
    Santilli, Giorgia
    Armant, Myriam
    Buckland, Karen F.
    Choi, Uimook
    De Ravin, Suk See
    Dorsey, Morna J.
    Kuo, Caroline Y.
    Leon-Rico, Diego
    Rivat, Christine
    Izotova, Natalia
    Gilmour, Kimberly
    Snell, Katie
    Dip, Jinhua Xu-Bayford
    Darwish, Jinan
    Morris, Emma C.
    Terrazas, Dayna
    Wang, Leo D.
    Bauser, Christopher A.
    Paprotka, Tobias
    Kuhns, Douglas B.
    Gregg, John
    Raymond, Hayley E.
    Everett, John K.
    Honnet, Geraldine
    Biasco, Luca
    Newburger, Peter E.
    Bushman, Frederic D.
    Grez, Manuel
    Gaspar, H. Bobby
    Williams, David A.
    Malech, Harry L.
    Galy, Anne
    Thrasher, Adrian J.
    Buckland, Karen F.
    Bauser, Christopher A.
    Honnet, Geraldine
    Grez, Manuel
    Gaspar, H. Bobby
    Galy, Anne
    Thrasher, Adrian J.
    NATURE MEDICINE, 2020, 26 (02) : 200 - +
  • [30] Unrelated cord blood transplantation using minimal-intensity conditioning in a 1.5-month-old infant with X-linked severe combined immunodeficiency
    Takeuchi, Shio
    Shigemura, Tomonari
    Shigeto, Shohei
    Murase, Tsubasa
    Morita, Daisuke
    Motobayashi, Mitsuo
    Takashi, Kurata
    Kobayashi, Norimoto
    Agematsu, Kazunaga
    Nakazawa, Yozo
    TRANSPLANT IMMUNOLOGY, 2024, 87
12345